STOCK TITAN

Major Exicure (NASDAQ: XCUR) holder sells $3.3M in stock

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Exicure HiTron Inc. filed Amendment No. 4 to its Schedule 13D on Exicure, Inc., updating its ownership after a significant share transfer. On January 16, 2026, Exicure HiTron completed the transfer of 734,747 shares of Exicure common stock at $4.50 per share, for total proceeds of $3,306,361.5. The shares were transferred to Daolam Co., Ltd (246,913 shares), Lee So Jung (243,918 shares), and Kim Jun Sue (243,916 shares).

After these transfers, Exicure HiTron reports beneficial ownership of 1,857,314 shares of Exicure common stock, representing approximately 29.2% of the 6,373,869 shares outstanding as reported in Exicure’s Form 10-Q. The filing reflects updated ownership and transaction details but does not change Exicure HiTron’s status as a major shareholder.

Positive

  • None.

Negative

  • None.

Insights

Large Exicure holder sells 734,747 shares but remains a near-30% owner.

The amendment shows Exicure HiTron Inc. completed a share transfer of 734,747 Exicure shares at $4.50 per share, for aggregate proceeds of $3,306,361.5. These blocks went to three buyers: Daolam Co., Ltd, Lee So Jung, and Kim Jun Sue, each receiving roughly a third of the total.

Following the transaction, Exicure HiTron reports beneficial ownership of 1,857,314 shares, or about 29.2% of Exicure’s 6,373,869 outstanding shares of common stock, using the share count from the Form 10-Q dated November 7, 2025. This indicates a reduced but still substantial position, keeping Exicure HiTron as a major shareholder with meaningful influence potential.

The filing also clarifies that all share numbers are as of January 16, 2026 and give effect to the transfers described. Subsequent ownership changes, if any, would be reflected in later disclosures.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D


Exicure HiTron Inc.
Signature: Young Chul Han
Name/Title:CEO
Date:01/20/2026

FAQ

What does Exicure HiTron Inc.'s latest Schedule 13D/A report for XCUR?

The amendment reports that Exicure HiTron Inc. transferred 734,747 Exicure common shares at $4.50 per share and updates its remaining beneficial ownership and percentage of the class.

How many Exicure (XCUR) shares does Exicure HiTron now beneficially own?

As of January 16, 2026, Exicure HiTron beneficially owns 1,857,314 shares of Exicure common stock, representing approximately 29.2% of the outstanding shares.

How many Exicure (XCUR) shares were transferred and at what price?

Exicure HiTron transferred an aggregate of 734,747 Exicure shares at a purchase price of $4.50 per share, for total proceeds of $3,306,361.5.

Who were the transferees in Exicure HiTron Inc.'s share transfer of XCUR stock?

The transferees were Daolam Co., Ltd (246,913 shares, $1,111,108.5), Lee So Jung (243,918 shares, $1,097,631), and Kim Jun Sue (243,916 shares, $1,097,622).

What share count did the filing use to calculate Exicure HiTron’s 29.2% ownership in XCUR?

The filing uses 6,373,869 shares of Exicure common stock, the number reported as outstanding on November 3, 2025 in Exicure’s Form 10-Q filed on November 7, 2025.

What type of entity is Exicure HiTron Inc., the reporting person for XCUR?

Exicure HiTron Inc. is identified as a South Korean corporation (citizenship or place of organization: Korea, Republic of) and is classified as a CO type of reporting person.
Exicure Inc

NASDAQ:XCUR

XCUR Rankings

XCUR Latest News

XCUR Latest SEC Filings

XCUR Stock Data

39.65M
2.38M
63.15%
12.88%
0.48%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHICAGO